Gene Editing Market by Product (Kits, Reagents, Libraries, Software), Service (Vector, Library Construction, Screening), Technique (Knock-Out), Technology (CRISPR, ZFN, RNAi, TALEN), Application, End User, Region, Competition - Global Forecast to 2031

Market Size
$5.23B
MARKET SIZE, 2026
Projected Market Size
$8.49B
MARKET SIZE, 2031
CAGR
10.1%
CAGR (2026-2031)
Forecast Period
2026-2031
FORECAST PERIOD

GENE EDITING MARKET SIZE, SHARE & GROWTH SNAPSHOT

genome-editing-engineering-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global gene editing market is projected to grow from USD 5.23 billion in 2026 to USD 8.49 billion by 2031, at a CAGR of 10.1% during the forecast period. The market was valued at USD 5.01 billion in 2025. Market growth is driven by technological advancements in CRISPR-based gene editing, increasing investments in genetic research, rising adoption of precision medicine, and growing applications of gene editing in drug discovery and development. Increasing demand for genetically engineered cell lines, functional genomic screening, and genetic medicine research is further supporting market expansion. Advances in base editing, prime editing, high-throughput screening technologies, automation, and bioinformatics solutions are expected to improve editing precision and broaden the research and therapeutic development applications of gene editing products and services.

KEY TAKEAWAYS

  • MARKET SNAPSHOT:
    Base Year Market Size (2025): USD 5.01 Billion
    Current Market Size (2026): USD 5.23 Billion
    Forecast Market Size (2031): USD 8.49 Billion
    CAGR (2026–2031): 10.1%
  • SEGMENT LEADERSHIP:
    Regional Leader: North America accounted for the largest share of the gene editing market in 2025, estimated at 45.9%.
    Product Leader: Gene editing products accounted for 70.0% of the global gene editing market in 2025.
    Fastest-Growing Product Segment: Reagents & consumables are expected to register the highest CAGR of 10.1% during the forecast period.
    Technique Leader: Knock-out accounted for the largest share of the gene editing reagents & consumables market in 2025.
    Technology Leader: CRISPR accounted for the largest share of the gene editing products market in 2025.
  • MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
    Major players include Thermo Fisher Scientific, Merck KGaA, GenScript, Agilent Technologies, Revvity, and Lonza Group, which are strengthening their positions through advanced CRISPR technologies, comprehensive reagent portfolios, specialized genome engineering services, product launches, strategic collaborations, and investments in precision editing technologies.
    Companies such as Synthego Corporation, Creative Biogene, AMSBIO, Precision BioSciences, Cellectis, and Caribou Biosciences participate in the broader gene editing ecosystem through specialized CRISPR technologies, genome engineering solutions, cell engineering capabilities, and proprietary editing platforms.

The gene editing market is growing steadily, driven by technological advancements in CRISPR-based genome editing, increasing investments in genetic research, and rising adoption of precision medicine. Growth is also supported by the expanding use of gene editing in drug discovery, cell line engineering, and therapeutic development. As pharmaceutical and biotechnology companies increasingly integrate genome editing technologies into research and development, demand for specialized reagents, kits, screening libraries, and gene editing services continues to increase. Advances in base editing, prime editing, automation, and bioinformatics are further expanding the research and commercial applications of gene editing technologies.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The rapid expansion of genetic research and precision medicine is reshaping the gene editing market. Over the forecast period from 2026 to 2031, gene editing technologies are expected to gain wider adoption across drug discovery and development, cell line engineering, functional genomics, and genetic medicine research. This transition is creating greater demand for CRISPR-based reagents and kits, gene editing libraries, advanced genome editing systems, and specialized gene editing services. At the same time, increasing investments in biotechnology research, growing applications of gene editing in therapeutic development, and advancements in base editing and prime editing are supporting market expansion. However, high costs of advanced gene editing technologies, off-target effects, regulatory complexities, and ethical concerns continue to influence adoption, encouraging innovation in precise genome editing, efficient delivery systems, automated workflows, and integrated gene engineering solutions.

genome-editing-engineering-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Advancements in precise genome editing technologies, including base editing and prime editing
  • Advancements in precise genome editing technologies, including base editing and prime editing
RESTRAINTS
Impact
Level
  • High costs associated with gene editing workflows and therapeutic development
OPPORTUNITIES
Impact
Level
  • Expanding applications of in vivo gene editing for genetic disorders
  • Integration of AI and machine learning into genome editing workflows
CHALLENGES
Impact
Level
  • Complex intellectual property landscape and CRISPR licensing restrictions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increasing adoption of CRISPR-based technologies in drug discovery and functional genomics

The increasing adoption of CRISPR-based technologies in drug discovery and functional genomics is a key factor driving the growth of the gene editing market. CRISPR technologies enable targeted genetic modifications, supporting drug target identification, gene function analysis, and disease modeling. Growing applications in pharmaceutical research, high-throughput genetic screening, and therapeutic development are increasing demand for gene editing reagents, kits, and specialized services. Continued advancements in CRISPR systems and expanding applications in functional genomics are expected to support market growth.

Restraint: High costs associated with gene editing workflows and therapeutic development

The high costs associated with gene editing workflows and therapeutic development are a major factor restraining broader market adoption. Advanced editing reagents, specialized delivery systems, laboratory instruments, and extensive genetic characterization procedures contribute to overall research expenditure. Additionally, therapeutic development requires comprehensive safety assessments, off-target analysis, process optimization, and stringent quality control. These requirements increase development costs and may limit adoption among smaller biotechnology companies and academic institutions, particularly in cost-sensitive markets.

Opportunity: Expanding applications of in vivo gene editing for genetic disorders

Expanding applications of in vivo gene editing are creating significant growth opportunities in the gene editing market. Advances in CRISPR-based technologies and targeted delivery systems are enabling researchers to modify disease-associated genes directly within the body. Increasing research on inherited genetic disorders, liver diseases, neurological conditions, and other therapeutic indications is broadening the potential applications of in vivo genome editing. Continued innovation in delivery technologies and editing platforms is expected to support demand for advanced gene editing reagents, specialized research tools, and development services.

Challenge: Complex intellectual property landscape and CRISPR licensing restrictions

The complex intellectual property landscape surrounding CRISPR technologies presents a significant challenge for gene editing product manufacturers and service providers. Overlapping patents, licensing requirements, and restrictions on commercial applications can complicate technology access and increase operational costs. Companies developing CRISPR-based reagents, editing platforms, and therapeutic applications must carefully evaluate intellectual property rights and licensing obligations. Addressing these challenges requires strategic licensing agreements, intellectual property management, and continued innovation in alternative editing technologies to support broader commercial adoption.

GENE EDITING MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Collaborates with Beam Therapeutics to develop in vivo base editing therapies targeting rare genetic diseases affecting the liver, muscles, and central nervous system. The programs utilize precision genome editing and lipid nanoparticle-based delivery technologies. Supports the development of targeted genetic medicines, enables precise modification of disease-associated DNA sequences, and advances research into potential treatments for inherited disorders.
company logo
Supports genome editing research through its Somatic Cell Genome Editing (SCGE) program, focusing on CRISPR-based technologies, targeted delivery systems, genome editing efficiency, and safety evaluation for therapeutic applications. Accelerates the development of genome editing tools, improves editing specificity and delivery efficiency, supports off-target analysis, and advances research into potential gene editing therapies for genetic diseases.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The gene editing market operates through an interconnected value chain spanning reagent and consumable manufacturers, software and system developers, specialized gene editing service providers, pharmaceutical and biotechnology companies, and research institutions. The upstream segment includes manufacturers of gene editing kits, guide RNAs, nucleases, donor DNA templates, plasmids, and screening libraries, along with developers of genome editing instruments and software solutions. In the midstream segment, gene editing service providers and specialized laboratories perform cell line development, gRNA synthesis, vector construction, library screening, genome engineering, and off-target analysis. Downstream, pharmaceutical and biotechnology companies, CROs & CDMOs, and academic and research institutes utilize these products and services in drug discovery, functional genomics, cell line engineering, therapeutic development, and genetic research. Across the value chain, editing efficiency, targeting specificity, delivery optimization, workflow reproducibility, and regulatory compliance are critical for reliable genome modification and the wider adoption of gene editing technologies.

genome-editing-engineering-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

genome-editing-engineering-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Gene Editing Market, By Offering

In 2025, the gene editing products segment accounted for the largest share of the global gene editing market, supported by recurring demand for CRISPR reagents, gene editing kits, screening libraries, and associated research instruments. Increasing applications in drug discovery, cell line engineering, and functional genomics, along with expanding genetic research activities, continue to support demand for gene editing products and services.

Gene Editing Products Market, By Product

In 2025, the reagents & consumables segment accounted for the largest share of the gene editing products market. Its dominance is driven by the recurring consumption of gene editing kits, guide RNAs, nucleases, screening libraries, and other reagents required for gene knockout, knock-in, and gene silencing workflows. Increasing genetic research activities and expanding applications in pharmaceutical and biotechnology research continue to support market growth.

Gene Editing Products Market, By Technique

In 2025, the knock-out segment accounted for the largest share of the gene editing reagents & consumables market. Its dominance is supported by extensive applications in functional genomics, drug target identification, disease modeling, and cell engineering. Increasing use of CRISPR-Cas9 reagents for targeted gene disruption and growing demand for genetically modified cellular models continue to support market growth.

Gene Editing Products Market, By Technology

In 2025, the CRISPR segment accounted for the largest share of the gene editing products market, supported by its versatility, efficient genome targeting, and widespread applications in genetic research. CRISPR-based technologies enable gene knockout, knock-in, and functional genomic screening across different cell types. Continued advancements in guide RNA design, editing specificity, and delivery technologies are expected to strengthen demand for CRISPR products.

Gene Editing Products Market, By Application

In 2025, the cell line engineering segment accounted for the largest share of the gene editing products market. This dominance is supported by increasing demand for genetically modified cell lines, knockout and knock-in models, and engineered cells used in research and biopharmaceutical production. Growing applications in biologics development, disease modeling, and cell-based therapeutic research continue to support demand for gene editing products.

Gene Editing Products Market, By End User

In 2025, pharmaceutical & biotechnology companies accounted for the largest share of the gene editing products market. This dominance is driven by extensive utilization of gene editing reagents, kits, and screening libraries in drug discovery, functional genomics, and therapeutic research. Increasing investments in genetic medicines, targeted therapies, and advanced cell engineering technologies continue to support demand from this end-user segment.

Gene Editing Services Market, By Service Type

In 2025, the cell line development & characterization segment accounted for the largest share of the gene editing services market. This dominance is driven by increasing demand for custom knockout and knock-in cell lines, genetically modified disease models, and specialized cell engineering services. Growing outsourcing of cell line development activities and expanding applications in biopharmaceutical production and therapeutic research continue to support segment growth.

Gene Editing Services Market, By Application

In 2025, the cell line engineering segment accounted for the largest share of the gene editing services market. Its dominance is supported by increasing outsourcing of customized genome modifications, engineered mammalian cell lines, and genetically modified research models. Growing demand for stable cell lines in biologics production, drug discovery, and therapeutic development continues to support adoption of specialized cell engineering services.

Gene Editing Services Market, By End User

In 2025, pharmaceutical & biotechnology companies accounted for the largest share of the gene editing services market. This dominance is driven by increasing outsourcing of customized genome engineering, cell line development, functional genomic screening, and specialized research activities. Growing investments in genetic medicines, expanding drug discovery pipelines, and increasing demand for technical expertise continue to support segment growth.

REGION

Asia Pacific to be the fastest-growing region in the gene editing market during the forecast period

The Asia Pacific gene editing market is expected to register the highest CAGR during the forecast period, supported by increasing investments in genetic research, expanding biotechnology infrastructure, and the growing adoption of CRISPR-based technologies. Countries such as China, Japan, South Korea, and India are strengthening their capabilities in genome engineering, cell line development, functional genomics, and genetic medicine research. Growth is also being supported by government initiatives promoting biotechnology innovation, rising pharmaceutical and biopharmaceutical R&D expenditure, and the expanding presence of regional gene editing product manufacturers and service providers. As pharmaceutical companies, biotechnology organizations, and research institutions increasingly adopt gene editing technologies for drug discovery, disease modeling, therapeutic development, and cell engineering, demand for gene editing reagents, kits, screening libraries, advanced systems, and specialized genome engineering services is expected to increase significantly.

genome-editing-engineering-market Region

GENE EDITING MARKET: COMPANY EVALUATION MATRIX

Within the current market framework, Thermo Fisher Scientific Inc. maintains a strong position in the gene editing market through its extensive portfolio of CRISPR-based reagents, gene editing kits, and molecular biology solutions. Its GeneArt CRISPR-Cas9 products, genome editing detection kits, and transfection technologies support targeted genetic modifications across drug discovery, cell line engineering, and functional genomics. Merck KGaA represents another major competitor, supported by its CRISPR reagents, synthetic guide RNAs, and genome engineering solutions for advanced genetic research. Continued investments in precision editing, high-throughput screening, and automated genome engineering workflows are enabling these companies to address growing demand for genetic medicines, drug discovery, and biotechnology research. Other prominent participants, including GenScript, Agilent Technologies, and Revvity, are strengthening their positions through specialized gene editing products, screening technologies, customized research services, and portfolio innovation.

genome-editing-engineering-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 5.01 billion
Market Forecast in 2026 (Value) USD 5.23 billion
Market Forecast in 2031 (Value) USD 8.49 billion
Growth Rate CAGR of 10.1% from 2026–2031
Years Considered 2023–2031
Base Year 2025
Forecast Period 2026–2031
Units Considered Value (USD Million/Billion)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Offering:
    • Products
    • Services
  • By Product Type:
    • Reagents & Consumables
    • Software & Systems
  • By Technology:
    • CRISPR
    • TALENs
    • ZFNs
    • Base Editing
    • Antisense
    • RNAi
    • Other Technologies
  • By Technique:
    • Knock-Out
    • Knock-In
    • Gene Silencing
    • Other Techniques
  • By Service Type:
    • Cell Line Development & Characterization
    • gRNA Synthesis & Vector Construction
    • Library Construction & Screening
    • Other Services
  • By Application:
    • Cell Line Engineering
    • Genome Editing/Genome Engineering
    • Drug Discovery & Development
    • Other Applications
  • By End User:
    • Pharmaceutical & Biotechnology Companies
    • Academic & Research Institutes
    • CROs & CDMOs
    • Other End Users.
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East, Africa

WHAT IS IN IT FOR YOU: GENE EDITING MARKET REPORT CONTENT GUIDE

genome-editing-engineering-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Gene Editing Market Assessment & Competitive Analysis Systematic assessment of the gene editing market, including market sizing and forecasting, product and service analysis, technology and technique evaluation, application and end-user assessment, regional analysis, competitive benchmarking, company profiling, and analysis of key growth drivers, restraints, opportunities, and challenges. Enables pharmaceutical and biotechnology companies, CROs & CDMOs, and research institutions to identify growth opportunities, evaluate competitive positioning, understand emerging gene editing technologies, and make informed strategic decisions regarding product development, research investments, technology adoption, and market expansion.

RECENT DEVELOPMENTS

  • October 2026 : Synthego and Biomay announced a collaboration to accelerate access to mRNA manufacturing and CRISPR solutions. The collaboration aims to support developers of advanced genetic medicines by combining specialized manufacturing capabilities with genome editing technologies.
  • September 2026 : Integrated DNA Technologies (IDT) and Aldevron, both Danaher companies, launched new research-grade Cas9 mRNA solutions in wild-type and SpyFi high-fidelity formats. The products are designed to support efficient genome editing, reduce off-target activity, and facilitate the transition from early-stage research to therapeutic development.
  • September 2025 : Revvity and Profluent announced a strategic collaboration to develop AI-enhanced adenine deaminase configurations for Revvity's Pin-point base editing platform. The collaboration combines AI-engineered proteins with modular base editing technology to improve editing precision, reduce unintended modifications, and support the development of gene editing therapies.

 

Table of Contents

checkmarkExclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
43
2
EXECUTIVE SUMMARY
 
 
 
 
 
47
3
PREMIUM INSIGHTS
 
 
 
 
 
53
4
MARKET OVERVIEW
CRISPR advancements and AI integration drive transformative growth in gene editing and therapeutic applications.
 
 
 
 
 
56
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
INCREASING ADOPTION OF CRISPR-BASED TECHNOLOGIES IN DRUG DISCOVERY AND FUNCTIONAL GENOMICS
 
 
 
 
 
 
4.2.1.2
ADVANCEMENTS IN PRECISE GENOME EDITING TECHNOLOGIES, INCLUDING BASE EDITING AND PRIME EDITING
 
 
 
 
 
 
4.2.1.3
GROWING DEMAND FOR GENETICALLY ENGINEERED CELL MODELS AND CELL-BASED THERAPIES
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
HIGH COSTS ASSOCIATED WITH GENE EDITING WORKFLOWS AND THERAPEUTIC DEVELOPMENT
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
EXPANDING APPLICATIONS OF IN VIVO GENE EDITING FOR GENETIC DISORDERS
 
 
 
 
 
 
4.2.3.2
INTEGRATION OF AI AND MACHINE LEARNING INTO GENOME EDITING WORKFLOWS
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
COMPLEX INTELLECTUAL PROPERTY LANDSCAPE AND CRISPR LICENSING RESTRICTIONS
 
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
 
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
5
INDUSTRY TRENDS
Navigate competitive dynamics and pricing shifts shaping the gene editing industry's future landscape.
 
 
 
 
 
62
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
THREAT OF NEW ENTRANTS
 
 
 
 
 
 
5.1.2
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.1.3
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.4
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
 
 
5.2.3
TRENDS IN GLOBAL GENE EDITING MARKET
 
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.5.1
AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023–2025
 
 
 
 
 
 
5.5.2
INDICATIVE PRICE TREND FOR GENE EDITING SERVICES
 
 
 
 
 
 
5.5.3
AVERAGE SELLING PRICE, BY REGION, 2025
 
 
 
 
 
5.6
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.6.1
IMPORT SCENARIO (HS CODE 3822.00)
 
 
 
 
 
 
5.6.2
EXPORT SCENARIO (HS CODE 3822.00)
 
 
 
 
 
 
5.6.3
IMPORT SCENARIO (HS CODE 3507.00)
 
 
 
 
 
 
5.6.4
EXPORT SCENARIO (HS CODE 3507.00)
 
 
 
 
 
 
5.6.5
IMPORT SCENARIO (HS CODE 2934.00)
 
 
 
 
 
 
5.6.6
EXPORT SCENARIO (HS CODE 2934.00)
 
 
 
 
 
5.7
KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
5.9
INVESTMENT/FUNDING ACTIVITY
 
 
 
 
 
 
 
5.9.1
VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
 
 
 
 
 
5.10
CASE STUDY ANALYSIS
 
 
 
 
 
 
 
5.10.1
CRISPR-BASED K-RAS KNOCKOUT CELL LINE DEVELOPMENT
 
 
 
 
 
 
5.10.2
HIGH-EFFICIENCY CRISPR EDITING OF PRIMARY HUMAN T CELLS
 
 
 
 
 
 
5.10.3
MULTIPLEX CRISPR EDITING FOR CHO CELL LINE OPTIMIZATION
 
 
 
 
 
5.11
IMPACT OF 2025 US TARIFFS—GENE EDITING MARKET
 
 
 
 
 
 
 
 
5.11.1
INTRODUCTION
 
 
 
 
 
 
5.11.2
KEY TARIFF RATES
 
 
 
 
 
 
5.11.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.11.4
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
 
 
5.11.4.1
NORTH AMERICA
 
 
 
 
 
 
5.11.4.2
EUROPE
 
 
 
 
 
 
5.11.4.3
ASIA PACIFIC
 
 
 
 
 
5.11.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
 
 
5.11.5.1
PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
5.11.5.2
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
5.11.5.3
CROS & CDMOS
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI-driven gene editing innovations redefine market dynamics and patent landscapes.
 
 
 
 
 
88
 
6.1
TECHNOLOGY ANALYSIS
 
 
 
 
 
 
 
6.1.1
KEY TECHNOLOGIES
 
 
 
 
 
 
 
6.1.1.1
AI-ENABLED & COMPUTATIONAL GENOME EDITING PLATFORMS
 
 
 
 
 
 
6.1.1.2
PRIME EDITING & BASE EDITING TECHNOLOGIES
 
 
 
 
 
6.1.2
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
6.1.2.1
RNA EDITING & EPIGENOME EDITING TECHNOLOGIES
 
 
 
 
 
 
6.1.2.2
ADVANCED GENE DELIVERY TECHNOLOGIES
 
 
 
 
 
6.1.3
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
6.1.3.1
SINGLE-CELL SEQUENCING & SPATIAL OMICS
 
 
 
 
 
 
6.1.3.2
NEXT-GENERATION SEQUENCING & HIGH-THROUGHPUT SCREENING
 
 
 
 
6.2
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
 
6.3
PATENT ANALYSIS
 
 
 
 
 
 
 
 
6.3.1
TOP APPLICANTS/OWNERS (COMPANIES) FOR GENE EDITING-RELATED PATENTS, 2015–2025
 
 
 
 
 
6.4
FUTURE APPLICATIONS
 
 
 
 
 
 
6.5
IMPACT OF AI/GEN AI ON GENE EDITING MARKET
 
 
 
 
 
 
 
 
6.5.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
 
6.5.2
CASE STUDIES OF AI IMPLEMENTATION IN GENE EDITING MARKET
 
 
 
 
 
 
6.5.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
6.5.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI
 
 
 
 
7
REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
Navigate complex regulations to enhance sustainability and achieve industry-leading eco-certifications.
 
 
 
 
 
96
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
 
 
7.2
SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
7.3
IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
7.4
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
 
 
 
 
 
8
CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
Understand gene editing market dynamics by analyzing decision-makers, criteria, and unmet industry needs.
 
 
 
 
 
101
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
 
 
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
 
 
 
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
8.2.2
KEY BUYING CRITERIA FOR GENE EDITING PRODUCTS, BY END USER
 
 
 
 
 
 
8.2.3
KEY BUYING CRITERIA FOR GENE EDITING SERVICES, BY END USER
 
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
 
8.5
MARKET PROFITABILITY
 
 
 
 
 
9
GENE EDITING MARKET, BY OFFERING
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 15 Data Tables
 
 
 
 
 
107
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
PRODUCTS
 
 
 
 
 
 
 
9.2.1
EXPANDING APPLICATIONS OF GENE MODIFICATION TECHNIQUES TO DRIVE MARKET
 
 
 
 
 
9.3
SERVICES
 
 
 
 
 
 
 
9.3.1
HIGH UPTAKE BY PHARMA COMPANIES FOR DRUG DISCOVERY & DEVELOPMENT TO PROPEL MARKET
 
 
 
 
10
GENE EDITING PRODUCTS MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 37 Data Tables
 
 
 
 
 
115
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
REAGENTS & CONSUMABLES
 
 
 
 
 
 
 
10.2.1
GENE EDITING KITS
 
 
 
 
 
 
 
10.2.1.1
INCREASING DEMAND FOR MUTATION & SCREENING KITS IN CLINICAL SETTINGS TO PROPEL MARKET
 
 
 
 
 
10.2.2
GENE EDITING LIBRARIES
 
 
 
 
 
 
 
10.2.2.1
GENETIC SCREENING FOR CANCER RESEARCH TO FUEL UPTAKE
 
 
 
 
 
10.2.3
GENE EDITING REAGENTS
 
 
 
 
 
 
 
10.2.3.1
ABILITY TO CREATE ANIMAL MODELS TO SUPPORT MARKET GROWTH
 
 
 
 
10.3
SOFTWARE & SYSTEMS
 
 
 
 
 
 
 
10.3.1
INTEGRATION OF CLOUD-BASED PLATFORMS FOR NGS TO DRIVE MARKET
 
 
 
 
11
GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 29 Data Tables
 
 
 
 
 
132
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
KNOCK-OUT
 
 
 
 
 
 
 
11.2.1
MODIFICATION OF CRISPR-CAS9 AND TALENS TO PROPEL MARKET
 
 
 
 
 
11.3
KNOCK-IN
 
 
 
 
 
 
 
11.3.1
UTILIZATION OF DONOR DNA TEMPLATES AND HDR PATHWAYS TO DRIVE MARKET
 
 
 
 
 
11.4
GENE SILENCING
 
 
 
 
 
 
 
11.4.1
ADVANCEMENTS IN RNAI TECHNOLOGY AND ANTISENSE THERAPY TO SUPPORT MARKET GROWTH
 
 
 
 
 
11.5
OTHER TECHNIQUES
 
 
 
 
 
12
GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 50 Data Tables
 
 
 
 
 
145
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
CRISPR
 
 
 
 
 
 
 
12.2.1
ADVANCEMENTS IN CAS9 PROTEINS TO FUEL UPTAKE
 
 
 
 
 
12.3
TALEN
 
 
 
 
 
 
 
12.3.1
INCREASING DEMAND FOR THERAPEUTIC DEVELOPMENT TO DRIVE MARKET
 
 
 
 
 
12.4
ZFN
 
 
 
 
 
 
 
12.4.1
PROVISION OF CUSTOMIZED DESIGN AND TARGETED EDITS TO BOOST DEMAND
 
 
 
 
 
12.5
BASE EDITING
 
 
 
 
 
 
 
12.5.1
GROWING APPLICATIONS IN FUNCTIONAL GENOMICS TO FUEL MARKET
 
 
 
 
 
12.6
ANTISENSE
 
 
 
 
 
 
 
12.6.1
INNOVATIONS IN OLIGONUCLEOTIDE THERAPIES TO SUPPORT MARKET GROWTH
 
 
 
 
 
12.7
RNAI
 
 
 
 
 
 
 
12.7.1
WIDE APPLICATIONS IN DRUG DISCOVERY TO FUEL UPTAKE
 
 
 
 
 
12.8
OTHER TECHNOLOGIES
 
 
 
 
 
13
GENE EDITING PRODUCTS MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 29 Data Tables
 
 
 
 
 
166
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
CELL LINE ENGINEERING
 
 
 
 
 
 
 
13.2.1
ABILITY TO PROVIDE PRECISE GENE MODIFICATIONS FOR VALIDATION TO DRIVE MARKET
 
 
 
 
 
13.3
GENOME EDITING
 
 
 
 
 
 
 
13.3.1
GROWING APPLICATIONS IN BIOTECHNOLOGY TO BOOST DEMAND
 
 
 
 
 
13.4
DRUG DISCOVERY & DEVELOPMENT
 
 
 
 
 
 
 
13.4.1
UPTAKE OF CRISPR-BASED SYSTEMS FOR DISEASE PROFILING TO DRIVE MARKET
 
 
 
 
 
13.5
OTHER APPLICATIONS
 
 
 
 
 
14
GENE EDITING PRODUCTS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 29 Data Tables
 
 
 
 
 
179
 
14.1
INTRODUCTION
 
 
 
 
 
 
14.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
 
14.2.1
INCREASING PRODUCT APPROVALS AND ROBUST CLINICAL PIPELINE TO PROPEL MARKET
 
 
 
 
 
14.3
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
 
14.3.1
FAVORABLE FUNDING FOR GENOMIC PROJECTS TO DRIVE MARKET
 
 
 
 
 
14.4
CROS & CDMOS
 
 
 
 
 
 
 
14.4.1
PROVISION OF SPECIALIZED EXPERTISE FOR CLINICAL TRIALS TO DRIVE MARKET
 
 
 
 
 
14.5
OTHER END USERS
 
 
 
 
 
15
GENE EDITING SERVICES MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 29 Data Tables
 
 
 
 
 
192
 
15.1
INTRODUCTION
 
 
 
 
 
 
15.2
CELL LINE DEVELOPMENT & ENGINEERING
 
 
 
 
 
 
 
15.2.1
GROWING DEMAND FOR BIOLOGICS AND BIOSIMILARS TO DRIVE MARKET
 
 
 
 
 
15.3
GRNA SYNTHESIS & VECTOR CONSTRUCTION
 
 
 
 
 
 
 
15.3.1
ADVANCEMENTS IN GENE EDITING TECHNOLOGIES AND DEMAND FOR PRECISE TARGETING TO DRIVE MARKET
 
 
 
 
 
15.4
LIBRARY CONSTRUCTION & SCREENING
 
 
 
 
 
 
 
15.4.1
INCREASING FOCUS ON HIGH-THROUGHPUT SCREENING TO PROPEL MARKET
 
 
 
 
 
15.5
OTHER SERVICES
 
 
 
 
 
16
GENE EDITING SERVICES MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 29 Data Tables
 
 
 
 
 
205
 
16.1
INTRODUCTION
 
 
 
 
 
 
16.2
CELL LINE ENGINEERING
 
 
 
 
 
 
 
16.2.1
HIGH UPTAKE IN R&D FOR THERAPEUTIC BIOPRODUCTION TO DRIVE MARKET
 
 
 
 
 
16.3
GENOME EDITING
 
 
 
 
 
 
 
16.3.1
GROWING FOCUS ON SYNTHETIC GENOMICS TO BOOST DEMAND
 
 
 
 
 
16.4
DRUG DISCOVERY & DEVELOPMENT
 
 
 
 
 
 
 
16.4.1
GROWING DEMAND FOR PHARMACEUTICAL DEVELOPMENT TO FUEL UPTAKE
 
 
 
 
 
16.5
OTHER APPLICATIONS
 
 
 
 
 
17
GENE EDITING SERVICES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 22 Data Tables
 
 
 
 
 
218
 
17.1
INTRODUCTION
 
 
 
 
 
 
17.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
 
17.2.1
GROWING DEMAND FOR ADVANCED MODALITIES TO DRIVE MARKET
 
 
 
 
 
17.3
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
 
17.3.1
INCREASING FUNDING FOR GENOMIC PROJECTS TO PROPEL MARKET
 
 
 
 
 
17.4
OTHER END USERS
 
 
 
 
 
18
GENE EDITING MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 17 Countries | 256 Data Tables.
 
 
 
 
 
229
 
18.1
INTRODUCTION
 
 
 
 
 
 
18.2
NORTH AMERICA
 
 
 
 
 
 
 
18.2.1
US
 
 
 
 
 
 
 
18.2.1.1
GROWING INVESTMENTS BY GOVERNMENT AUTHORITIES AND PRIVATE PLAYERS TO DRIVE MARKET
 
 
 
 
 
18.2.2
CANADA
 
 
 
 
 
 
 
18.2.2.1
RISE IN RESEARCH & DEVELOPMENT INITIATIVES FOR GENOMICS AND BIOTECHNOLOGY TO AUGMENT GROWTH
 
 
 
 
18.3
EUROPE
 
 
 
 
 
 
 
18.3.1
GERMANY
 
 
 
 
 
 
 
18.3.1.1
GROWING FOCUS ON PROMOTING INNOVATIONS IN BIOTECHNOLOGY SECTOR TO BOOST MARKET
 
 
 
 
 
18.3.2
FRANCE
 
 
 
 
 
 
 
18.3.2.1
ONGOING CLINICAL TRIALS AND ADVANCED GENOMIC RESEARCH TO PROMOTE GROWTH
 
 
 
 
 
18.3.3
UK
 
 
 
 
 
 
 
18.3.3.1
GROWING FOCUS ON DEVELOPING CELL AND GENE THERAPY INFRASTRUCTURE TO FUEL MARKET
 
 
 
 
 
18.3.4
ITALY
 
 
 
 
 
 
 
18.3.4.1
INCREASING AVAILABILITY OF RESEARCH FUNDS TO EXPEDITE GROWTH
 
 
 
 
 
18.3.5
SPAIN
 
 
 
 
 
 
 
18.3.5.1
BOOMING BIOTECHNOLOGY SECTOR TO CONTRIBUTE TO MARKET GROWTH
 
 
 
 
 
18.3.6
REST OF EUROPE
 
 
 
 
 
18.4
ASIA PACIFIC
 
 
 
 
 
 
 
18.4.1
CHINA
 
 
 
 
 
 
 
18.4.1.1
INCREASING AFFORDABILITY OF SEQUENCING PLATFORMS AND PROCEDURES TO FAVOR GROWTH
 
 
 
 
 
18.4.2
JAPAN
 
 
 
 
 
 
 
18.4.2.1
GROWING FOCUS ON CANCER RESEARCH TO FUEL MARKET
 
 
 
 
 
18.4.3
INDIA
 
 
 
 
 
 
 
18.4.3.1
INCREASED AWARENESS ABOUT THERAPEUTIC BENEFITS OF GENOME ENGINEERING TO ENCOURAGE GROWTH
 
 
 
 
 
18.4.4
SOUTH KOREA
 
 
 
 
 
 
 
18.4.4.1
RISING INCLINATION TOWARD IN VIVO GENE EDITING TO STIMULATE GROWTH
 
 
 
 
 
18.4.5
AUSTRALIA
 
 
 
 
 
 
 
18.4.5.1
FAVORABLE REGULATORY LANDSCAPE TO SUSTAIN GROWTH
 
 
 
 
 
18.4.6
REST OF ASIA PACIFIC
 
 
 
 
 
18.5
LATIN AMERICA
 
 
 
 
 
 
 
18.5.1
BRAZIL
 
 
 
 
 
 
 
18.5.1.1
SUPPORTIVE REGULATORY FRAMEWORK FOR BIOTECHNOLOGY INNOVATION TO FUEL MARKET
 
 
 
 
 
18.5.2
REST OF LATIN AMERICA
 
 
 
 
 
18.6
MIDDLE EAST
 
 
 
 
 
 
 
18.6.1
GCC COUNTRIES
 
 
 
 
 
 
 
18.6.1.1
KINGDOM OF SAUDI ARABIA
 
 
 
 
 
 
 
 
18.6.1.1.1
INCREASING ESTABLISHMENT OF BIOTECH STARTUPS TO SUPPORT MARKET GROWTH
 
 
 
 
18.6.1.2
UNITED ARAB EMIRATES (UAE)
 
 
 
 
 
 
 
 
18.6.1.2.1
GROWING COLLABORATIONS FOR GENOME SEQUENCING TO DRIVE MARKET
 
 
 
 
18.6.1.3
OTHER GCC COUNTRIES
 
 
 
 
 
18.6.2
REST OF MIDDLE EAST
 
 
 
 
 
18.7
AFRICA
 
 
 
 
 
 
 
18.7.1
IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
 
 
 
 
19
COMPETITIVE LANDSCAPE
Discover key players' strategies and market dominance shaping future competitive dynamics.
 
 
 
 
 
335
 
19.1
INTRODUCTION
 
 
 
 
 
 
19.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
 
19.3
REVENUE ANALYSIS, 2021–2025
 
 
 
 
 
 
 
19.4
MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
 
 
19.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
 
 
 
 
 
 
 
 
19.5.1
STARS
 
 
 
 
 
 
19.5.2
EMERGING LEADERS
 
 
 
 
 
 
19.5.3
PERVASIVE PLAYERS
 
 
 
 
 
 
19.5.4
PARTICIPANTS
 
 
 
 
 
 
19.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
19.5.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
19.5.5.2
REGION FOOTPRINT
 
 
 
 
 
 
19.5.5.3
PRODUCT FOOTPRINT
 
 
 
 
 
 
19.5.5.4
SERVICE FOOTPRINT
 
 
 
 
 
 
19.5.5.5
TECHNOLOGY FOOTPRINT
 
 
 
 
 
 
19.5.5.6
APPLICATION FOOTPRINT
 
 
 
 
19.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
 
19.6.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
19.6.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
19.6.3
DYNAMIC COMPANIES
 
 
 
 
 
 
19.6.4
STARTING BLOCKS
 
 
 
 
 
 
19.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
19.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
19.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
19.7
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
 
 
 
19.7.1
VALUATION OF KEY PLAYERS
 
 
 
 
 
 
19.7.2
FINANCIAL METRICS OF KEY PLAYERS
 
 
 
 
 
19.8
BRAND COMPARISON
 
 
 
 
 
 
 
19.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
19.9.1
PRODUCT & SERVICE LAUNCHES
 
 
 
 
 
 
19.9.2
DEALS
 
 
 
 
 
 
19.9.3
EXPANSIONS
 
 
 
 
20
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
357
 
20.1
KEY PLAYERS
 
 
 
 
 
 
 
20.1.1
THERMO FISHER SCIENTIFIC INC.
 
 
 
 
 
 
 
20.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
20.1.1.2
PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
20.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
20.1.1.3.1
PRODUCT/SERVICE LAUNCHES
 
 
 
 
 
 
20.1.1.3.2
EXPANSIONS
 
 
 
 
20.1.1.4
MNM VIEW
 
 
 
 
 
 
 
 
20.1.1.4.1
KEY STRENGTHS
 
 
 
 
 
 
20.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
20.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
 
 
 
20.1.2
AGILENT TECHNOLOGIES, INC.
 
 
 
 
 
 
20.1.3
MERCK KGAA
 
 
 
 
 
 
20.1.4
REVVITY, INC.
 
 
 
 
 
 
20.1.5
GENSCRIPT
 
 
 
 
 
 
20.1.6
LONZA
 
 
 
 
 
 
20.1.7
TECAN TRADING AG
 
 
 
 
 
 
20.1.8
SANGAMO THERAPEUTICS
 
 
 
 
 
 
20.1.9
PRECISION BIOSCIENCES
 
 
 
 
 
 
20.1.10
CELLECTIS S.A.
 
 
 
 
 
 
20.1.11
REGENERON PHARMACEUTICALS, INC.
 
 
 
 
 
 
20.1.12
AMSBIO
 
 
 
 
 
 
20.1.13
CREATIVE BIOGENE
 
 
 
 
 
 
20.1.14
SYNTHEGO
 
 
 
 
 
 
20.1.15
TAKARA BIO INC.
 
 
 
 
 
 
20.1.16
CARIBOU BIOSCIENCES, INC.
 
 
 
 
 
 
20.1.17
BIONEER CORPORATION
 
 
 
 
 
 
20.1.18
REPROCELL INC.
 
 
 
 
 
 
20.1.19
ORIGENE TECHNOLOGIES, INC.
 
 
 
 
 
20.2
OTHER PLAYERS
 
 
 
 
 
 
 
20.2.1
ALSTEM INC.
 
 
 
 
 
 
20.2.2
INTEGRATED DNA TECHNOLOGIES, INC. (DANAHER)
 
 
 
 
 
 
20.2.3
BIOCAT GMBH
 
 
 
 
 
 
20.2.4
NEW ENGLAND BIOLABS
 
 
 
 
 
 
20.2.5
COBO TECHNOLOGIES APS
 
 
 
 
 
 
20.2.6
GENECOPOEIA, INC.
 
 
 
 
 
 
20.2.7
HERA BIOLABS
 
 
 
 
 
 
20.2.8
STEMCELL TECHNOLOGIES
 
 
 
 
 
 
20.2.9
AXOL BIOSCIENCE LTD.
 
 
 
 
 
 
20.2.10
CELLECTA, INC.
 
 
 
 
 
 
20.2.11
APPLIED STEMCELL
 
 
 
 
21
RESEARCH METHODOLOGY
 
 
 
 
 
432
 
21.1
RESEARCH DATA
 
 
 
 
 
 
 
21.1.1
SECONDARY DATA
 
 
 
 
 
 
21.1.2
PRIMARY DATA
 
 
 
 
 
21.2
MARKET ESTIMATION METHODOLOGY
 
 
 
 
 
 
 
21.2.1
MARKET SIZE ESTIMATION
 
 
 
 
 
 
21.2.2
INSIGHTS OF PRIMARY EXPERTS
 
 
 
 
 
 
21.2.3
TOP-DOWN APPROACH
 
 
 
 
 
21.3
MARKET GROWTH RATE PROJECTIONS
 
 
 
 
 
 
21.4
MARKET BREAKDOWN AND DATA TRIANGULATION
 
 
 
 
 
 
21.5
RESEARCH ASSUMPTIONS
 
 
 
 
 
 
21.6
RESEARCH LIMITATIONS
 
 
 
 
 
 
21.7
RISK ANALYSIS
 
 
 
 
 
22
APPENDIX
 
 
 
 
 
445
 
22.1
DISCUSSION GUIDE
 
 
 
 
 
 
22.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
22.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
22.4
RELATED REPORTS
 
 
 
 
 
 
22.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
GENE EDITING MARKET: IMPACT ANALYSIS
 
 
 
 
 
 
TABLE 2
GENE EDITING MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
TABLE 3
GENE EDITING MARKET: ROLE IN ECOSYSTEM
 
 
 
 
 
 
TABLE 4
AVERAGE SELLING PRICE TREND OF REAGENTS & CONSUMABLES, BY KEY PLAYER, 2023–2025
 
 
 
 
 
 
TABLE 5
AVERAGE SELLING PRICE OF REAGENTS & CONSUMABLES, BY REGION, 2025 (USD)
 
 
 
 
 
 
TABLE 6
IMPORT DATA FOR HS CODE 3822.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 7
EXPORT DATA FOR HS CODE 3822.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 8
IMPORT DATA FOR HS CODE 3507.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 9
EXPORT DATA FOR HS CODE 3507.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 10
IMPORT DATA FOR HS CODE 2934.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 11
EXPORT DATA FOR HS CODE 2934.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 12
GENE EDITING MARKET: KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
TABLE 13
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 14
INDICATIVE LIST OF PATENTS IN GENE EDITING MARKET, 2024–2026
 
 
 
 
 
 
TABLE 15
CASE STUDIES OF AI IMPLEMENTATION IN GENE EDITING MARKET
 
 
 
 
 
 
TABLE 16
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN GENE EDITING MARKET
 
 
 
 
 
 
TABLE 17
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 18
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
 
 
 
 
 
 
TABLE 19
KEY BUYING CRITERIA FOR GENE EDITING PRODUCTS, BY END USER
 
 
 
 
 
 
TABLE 20
KEY BUYING CRITERIA FOR GENE EDITING SERVICES, BY END USER
 
 
 
 
 
 
TABLE 21
GENE EDITING MARKET, BY OFFERING, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 22
GENE EDITING PRODUCTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 23
NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 24
EUROPE: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 25
ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 26
LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 27
MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 28
GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 29
GENE EDITING SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 30
NORTH AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 31
EUROPE: GENE EDITING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 32
ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 33
LATIN AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 34
MIDDLE EAST: GENE EDITING SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 35
GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 36
GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 37
GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 38
GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 39
NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 40
EUROPE: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 41
ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 42
LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 43
MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 44
GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 45
GENE EDITING KITS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 46
NORTH AMERICA: GENE EDITING KITS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 47
EUROPE: GENE EDITING KITS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 48
ASIA PACIFIC: GENE EDITING KITS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 49
LATIN AMERICA: GENE EDITING KITS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 50
MIDDLE EAST: GENE EDITING KITS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 51
GCC COUNTRIES: GENE EDITING KITS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 52
GENE EDITING LIBRARIES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 53
NORTH AMERICA: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 54
EUROPE: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 55
ASIA PACIFIC: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 56
LATIN AMERICA: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 57
MIDDLE EAST: GENE EDITING LIBRARIES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 58
GCC COUNTRIES: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 59
GENE EDITING REAGENTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 60
NORTH AMERICA: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 61
EUROPE: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 62
ASIA PACIFIC: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 63
LATIN AMERICA: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 64
MIDDLE EAST: GENE EDITING REAGENTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 65
GCC COUNTRIES: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 66
GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 67
NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 68
EUROPE: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 69
ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 70
LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 71
MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 72
GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 73
GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 74
KNOCK-OUT TECHNIQUE MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 75
NORTH AMERICA: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 76
EUROPE: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 77
ASIA PACIFIC: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 78
LATIN AMERICA: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 79
MIDDLE EAST: KNOCK-OUT TECHNIQUE MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 80
GCC COUNTRIES: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 81
KNOCK-IN TECHNIQUE MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 82
NORTH AMERICA: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 83
EUROPE: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 84
ASIA PACIFIC: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 85
LATIN AMERICA: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 86
MIDDLE EAST: KNOCK-IN TECHNIQUE MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 87
GCC COUNTRIES: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 88
GENE SILENCING TECHNIQUE MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 89
NORTH AMERICA: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 90
EUROPE: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 91
ASIA PACIFIC: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 92
LATIN AMERICA: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 93
MIDDLE EAST: GENE SILENCING TECHNIQUE MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 94
GCC COUNTRIES: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 95
OTHER TECHNIQUES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 96
NORTH AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 97
EUROPE: OTHER TECHNIQUES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 98
ASIA PACIFIC: OTHER TECHNIQUES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 99
LATIN AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 100
MIDDLE EAST: OTHER TECHNIQUES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 101
GCC COUNTRIES: OTHER TECHNIQUES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 102
GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 103
GENE EDITING PRODUCTS MARKET FOR CRISPR, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 104
NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 105
EUROPE: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 106
ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 107
LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 108
MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 109
GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 110
GENE EDITING PRODUCTS MARKET FOR TALEN, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 111
NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 112
EUROPE: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 113
ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 114
LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 115
MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR TALEN, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 116
GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 117
GENE EDITING PRODUCTS MARKET FOR ZFN, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 118
NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 119
EUROPE: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 120
ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 121
LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 122
MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR ZFN, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 123
GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 124
GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 125
NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 126
EUROPE: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 127
ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 128
LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 129
MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 130
GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 131
GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 132
NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 133
EUROPE: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 134
ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 135
LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 136
MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 137
GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 138
GENE EDITING PRODUCTS MARKET FOR RNAI, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 139
NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 140
EUROPE: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 141
ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 142
LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 143
MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR RNAI, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 144
GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 145
GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 146
NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 147
EUROPE: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 148
ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 149
LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 150
MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 151
GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 152
GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 153
CELL LINE ENGINEERING PRODUCTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 154
NORTH AMERICA: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 155
EUROPE: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 156
ASIA PACIFIC: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 157
LATIN AMERICA: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 158
MIDDLE EAST: CELL LINE ENGINEERING PRODUCTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 159
GCC COUNTRIES: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 160
GENOME EDITING PRODUCTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 161
NORTH AMERICA: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 162
EUROPE: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 163
ASIA PACIFIC: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 164
LATIN AMERICA: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 165
MIDDLE EAST: GENOME EDITING PRODUCTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 166
GCC COUNTRIES: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 167
DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 168
NORTH AMERICA: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 169
EUROPE: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 170
ASIA PACIFIC: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 171
LATIN AMERICA: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 172
MIDDLE EAST: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 173
GCC COUNTRIES: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 174
GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 175
NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 176
EUROPE: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 177
ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 178
LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 179
MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 180
GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 181
GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 182
GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 183
NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 184
EUROPE: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 185
ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 186
LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 187
MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 188
GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 189
GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 190
NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 191
EUROPE: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 192
ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 193
LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 194
MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 195
GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 196
GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 197
NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 198
EUROPE: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 199
ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 200
LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 201
MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 202
GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 203
GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 204
NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 205
EUROPE: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 206
ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 207
LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 208
MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 209
GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 210
GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 211
CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 212
NORTH AMERICA: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 213
EUROPE: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 214
ASIA PACIFIC: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 215
LATIN AMERICA: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 216
MIDDLE EAST: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 217
GCC COUNTRIES: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 218
GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 219
NORTH AMERICA: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 220
EUROPE: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 221
ASIA PACIFIC: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 222
LATIN AMERICA: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 223
MIDDLE EAST: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 224
GCC COUNTRIES: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 225
IBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 226
NORTH AMERICA: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 227
EUROPE: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 228
ASIA PACIFIC: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 229
LATIN AMERICA: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 230
MIDDLE EAST: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 231
GCC COUNTRIES: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 232
GENE EDITING MARKET FOR OTHER SERVICES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 233
NORTH AMERICA: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 234
EUROPE: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 235
ASIA PACIFIC: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 236
LATIN AMERICA: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 237
MIDDLE EAST: GENE EDITING MARKET FOR OTHER SERVICES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 238
GCC COUNTRIES: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 239
GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 240
CELL LINE ENGINEERING SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 241
NORTH AMERICA: CELL LINE ENGINEERING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 242
EUROPE: CELL LINE ENGINEERING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 243
ASIA PACIFIC: CELL LINE ENGINEERING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 244
LATIN AMERICA: CELL LINE ENGINEERING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 245
MIDDLE EAST: CELL LINE ENGINEERING SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 246
GCC COUNTRIES: CELL LINE ENGINEERING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 247
GENOME EDITING SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 248
NORTH AMERICA: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 249
EUROPE: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 250
ASIA PACIFIC: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 251
LATIN AMERICA: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 252
MIDDLE EAST: GENOME EDITING SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 253
GCC COUNTRIES: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 254
DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 255
NORTH AMERICA: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 256
EUROPE: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 257
ASIA PACIFIC: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 258
LATIN AMERICA: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 259
MIDDLE EAST: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 260
GCC COUNTRIES: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 261
GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 262
NORTH AMERICA: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 263
EUROPE: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 264
ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 265
LATIN AMERICA: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 266
MIDDLE EAST: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 267
GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 268
GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 269
GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 270
NORTH AMERICA: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 271
EUROPE: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 272
ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 273
LATIN AMERICA: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 274
MIDDLE EAST: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 275
GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 276
GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 277
NORTH AMERICA: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 278
EUROPE: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 279
ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 280
LATIN AMERICA: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 281
MIDDLE EAST: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 282
GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 283
GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 284
NORTH AMERICA: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 285
EUROPE: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 286
ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 287
LATIN AMERICA: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 288
MIDDLE EAST: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 289
GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 290
GENE EDITING PRODUCTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 291
GENE EDITING SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 292
NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 293
NORTH AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 294
NORTH AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 295
NORTH AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 296
NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 297
NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 298
NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 299
NORTH AMERICA: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 300
NORTH AMERICA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 301
NORTH AMERICA: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 302
US: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 303
US: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 304
US: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 305
US: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 306
US: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 307
US: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 308
US: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 309
US: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 310
US: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 311
CANADA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 312
CANADA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 313
CANADA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 314
CANADA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 315
CANADA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 316
CANADA: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 317
CANADA: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 318
CANADA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 319
CANADA: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 320
EUROPE: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 321
EUROPE: GENE EDITING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 322
EUROPE: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 323
EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 324
EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 325
EUROPE: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 326
EUROPE: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 327
EUROPE: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 328
EUROPE: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 329
EUROPE: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 330
EUROPE: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 331
GERMANY: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 332
GERMANY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 333
GERMANY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 334
GERMANY: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 335
GERMANY: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 336
GERMANY: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 337
GERMANY: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 338
GERMANY: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 339
GERMANY: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 340
FRANCE: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 341
FRANCE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 342
FRANCE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 343
FRANCE: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 344
FRANCE: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 345
FRANCE: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 346
FRANCE: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 347
FRANCE: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 348
FRANCE: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 349
UK: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 350
UK: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 351
UK: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 352
UK: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 353
UK: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 354
UK: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 355
UK: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 356
UK: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 357
UK: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 358
ITALY: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 359
ITALY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 360
ITALY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 361
ITALY: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 362
ITALY: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 363
ITALY: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 364
ITALY: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 365
ITALY: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 366
ITALY: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 367
SPAIN: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 368
SPAIN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 369
SPAIN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 370
SPAIN: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 371
SPAIN: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 372
SPAIN: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 373
SPAIN: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 374
SPAIN: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 375
SPAIN: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 376
REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 377
REST OF EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 378
REST OF EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 379
REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 380
REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 381
REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 382
REST OF EUROPE: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 383
REST OF EUROPE: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 384
REST OF EUROPE: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 385
ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 386
ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 387
ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 388
ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 389
ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 390
ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 391
ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 392
ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 393
ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 394
ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 395
ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 396
CHINA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 397
CHINA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 398
CHINA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 399
CHINA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 400
CHINA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 401
CHINA: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 402
CHINA: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 403
CHINA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 404
CHINA: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 405
JAPAN: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 406
JAPAN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 407
JAPAN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 408
JAPAN: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 409
JAPAN: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 410
JAPAN: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 411
JAPAN: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 412
JAPAN: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 413
JAPAN: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 414
INDIA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 415
INDIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 416
INDIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 417
INDIA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 418
INDIA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 419
INDIA: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 420
INDIA: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 421
INDIA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 422
INDIA: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 423
SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 424
SOUTH KOREA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 425
SOUTH KOREA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 426
SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 427
SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 428
SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 429
SOUTH KOREA: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 430
SOUTH KOREA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 431
SOUTH KOREA: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 432
AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 433
AUSTRALIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 434
AUSTRALIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 435
AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 436
AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 437
AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 438
AUSTRALIA: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 439
AUSTRALIA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 440
AUSTRALIA: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 441
REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 442
REST OF ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 443
REST OF ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 444
REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 445
REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 446
REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 447
REST OF ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 448
REST OF ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 449
REST OF ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 450
LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 451
LATIN AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 452
LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 453
LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 454
LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 455
LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 456
LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 457
LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 458
LATIN AMERICA: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 459
LATIN AMERICA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 460
LATIN AMERICA: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 461
BRAZIL: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 462
BRAZIL: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 463
BRAZIL: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 464
BRAZIL: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 465
BRAZIL: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 466
BRAZIL: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 467
BRAZIL: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 468
BRAZIL: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 469
BRAZIL: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 470
REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 471
REST OF LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 472
REST OF LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 473
REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 474
REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 475
REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 476
REST OF LATIN AMERICA: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 477
REST OF LATIN AMERICA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 478
REST OF LATIN AMERICA: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 479
MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 480
MIDDLE EAST: GENE EDITING SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 481
MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 482
MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 483
MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 484
MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 485
MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 486
MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 487
MIDDLE EAST: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 488
MIDDLE EAST: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 489
MIDDLE EAST: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 490
GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 491
GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 492
GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 493
GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 494
GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 495
GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 496
GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 497
GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 498
GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 499
GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 500
GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 501
KSA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 502
KSA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 503
KSA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 504
KSA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 505
KSA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 506
KSA: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 507
KSA: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 508
KSA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 509
KSA: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 510
UAE: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 511
UAE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 512
UAE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 513
UAE: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 514
UAE: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 515
UAE: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 516
UAE: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 517
UAE: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 518
UAE: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 519
OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 520
OTHER GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 521
OTHER GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 522
OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 523
OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 524
OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 525
OTHER GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 526
OTHER GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 527
OTHER GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 528
REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 529
REST OF MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 530
REST OF MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 531
REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 532
REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 533
REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 534
REST OF MIDDLE EAST: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 535
REST OF MIDDLE EAST: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 536
REST OF MIDDLE EAST: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 537
AFRICA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 538
AFRICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 539
AFRICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 540
AFRICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 541
AFRICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 542
AFRICA: GENE EDITING PRODUCTS MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 543
AFRICA: GENE EDITING SERVICES MARKET, BY TYPE, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 544
AFRICA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 545
AFRICA: GENE EDITING SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 546
OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN GENE EDITING MARKET
 
 
 
 
 
 
TABLE 547
GENE EDITING MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 548
GENE EDITING MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 549
GENE EDITING MARKET: PRODUCT FOOTPRINT
 
 
 
 
 
 
TABLE 550
GENE EDITING MARKET: SERVICE FOOTPRINT
 
 
 
 
 
 
TABLE 551
GENE EDITING MARKET: TECHNOLOGY FOOTPRINT
 
 
 
 
 
 
TABLE 552
GENE EDITING MARKET: APPLICATION FOOTPRINT
 
 
 
 
 
 
TABLE 553
GENE EDITING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
TABLE 554
GENE EDITING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
 
 
TABLE 555
GENE EDITING MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 556
GENE EDITING MARKET: DEALS, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 557
GENE EDITING MARKET: EXPANSIONS, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 558
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 559
THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 560
THERMO FISHER SCIENTIFIC INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 561
THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 562
AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 563
AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 564
AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 565
AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 566
MERCK KGAA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 567
MERCK KGAA: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 568
MERCK KGAA: PRODUCT/SERVICE LAUNCHES, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 569
MERCK KGAA: DEALS, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 570
REVVITY, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 571
REVVITY, INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 572
REVVITY, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 573
REVVITY, INC.: DEALS, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 574
GENSCRIPT: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 575
GENSCRIPT: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 576
GENSCRIPT: PRODUCT/SERVICE LAUNCHES, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 577
GENSCRIPT: DEALS, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 578
GENSCRIPT: EXPANSIONS, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 579
LONZA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 580
LONZA: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 581
LONZA: PRODUCT/SERVICE LAUNCHES, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 582
LONZA: DEALS, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 583
TECAN TRADING AG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 584
TECAN TRADING AG: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 585
TECAN TRADING AG: PRODUCT/SERVICE LAUNCHES, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 586
TECAN TRADING AG: DEALS, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 587
SANGAMO THERAPEUTICS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 588
SANGAMO THERAPEUTICS: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 589
SANGAMO THERAPEUTICS: DEALS, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 590
PRECISION BIOSCIENCES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 591
PRECISION BIOSCIENCES: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 592
CELLECTIS S.A.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 593
CELLECTIS S.A.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 594
REGENERON PHARMACEUTICALS, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 595
REGENERON PHARMACEUTICALS, INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 596
REGENERON PHARMACEUTICALS, INC.: DEALS, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 597
AMSBIO: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 598
AMSBIO: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 599
CREATIVE BIOGENE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 600
CREATIVE BIOGENE: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 601
CREATIVE BIOGENE: PRODUCT/SERVICE LAUNCHES, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 602
SYNTHEGO: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 603
SYNTHEGO: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 604
SYNTHEGO: PRODUCT/SERVICE LAUNCHES, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 605
SYNTHEGO: DEALS, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 606
SYNTHEGO: EXPANSIONS, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 607
TAKARA BIO INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 608
TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 609
TAKARA BIO INC.: DEALS, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 610
CARIBOU BIOSCIENCES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 611
CARIBOU BIOSCIENCES, INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 612
CARIBOU BIOSCIENCES, INC.: DEALS, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 613
BIONEER CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 614
BIONEER CORPORATION: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 615
REPROCELL INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 616
REPROCELL INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 617
REPROCELL INC.: DEALS, JANUARY 2023–OCTOBER 2026
 
 
 
 
 
 
TABLE 618
ORIGENE TECHNOLOGIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 619
ORIGENE TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 620
ALSTEM INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 621
INTEGRATED DNA TECHNOLOGIES, INC. (DANAHER): COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 622
BIOCAT GMBH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 623
NEW ENGLAND BIOLABS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 624
COBO TECHNOLOGIES APS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 625
GENECOPOEIA, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 626
HERA BIOLABS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 627
STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 628
AXOL BIOSCIENCE LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 629
CELLECTA, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 630
APPLIED STEMCELL: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 631
IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
MARKET SCENARIO
 
 
 
 
 
 
FIGURE 2
GLOBAL GENE EDITING MARKET, 2024–2031
 
 
 
 
 
 
FIGURE 3
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN GENE EDITING MARKET, 2023–2026
 
 
 
 
 
 
FIGURE 4
DISRUPTIONS INFLUENCING THE GROWTH OF GENE EDITING MARKET
 
 
 
 
 
 
FIGURE 5
HIGH-GROWTH SEGMENTS IN GENE EDITING MARKET, 2026–2031
 
 
 
 
 
 
FIGURE 6
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN GENE EDITING MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 7
ADVANCEMENTS IN PRECISE GENOME EDITING TECHNOLOGIES, INCLUDING BASE EDITING AND PRIME EDITING
 
 
 
 
 
 
FIGURE 8
REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA IN 2025
 
 
 
 
 
 
FIGURE 9
CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 10
KNOCK-OUT SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 11
GENE EDITING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 12
GENE EDITING MARKET: PORTER'S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 13
GENE EDITING MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 14
GENE EDITING MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 15
AVERAGE SELLING PRICE OF REAGENTS & CONSUMABLES, BY KEY PLAYER (2025)
 
 
 
 
 
 
FIGURE 16
AVERAGE SELLING PRICE OF REAGENTS & CONSUMABLES, BY REGION, 2025 (USD)
 
 
 
 
 
 
FIGURE 17
GENE EDITING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
 
FIGURE 18
TOP APPLICANTS/OWNERS (COMPANIES) FOR GENE EDITING-RELATED PATENTS, 2015–2025
 
 
 
 
 
 
FIGURE 19
IMPACT OF AI/GEN AI ON GENE EDITING MARKET
 
 
 
 
 
 
FIGURE 20
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
 
 
 
 
 
 
FIGURE 21
KEY BUYING CRITERIA FOR GENE EDITING PRODUCTS, BY END USER
 
 
 
 
 
 
FIGURE 22
KEY BUYING CRITERIA FOR GENE EDITING SERVICES, BY END USER
 
 
 
 
 
 
FIGURE 23
NORTH AMERICA: GENE EDITING MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 24
ASIA PACIFIC: GENE EDITING MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 25
REVENUE ANALYSIS OF KEY PLAYERS, 2021–2025 (USD MILLION)
 
 
 
 
 
 
FIGURE 26
MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
 
 
 
 
 
 
FIGURE 27
GENE EDITING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
 
 
 
 
 
 
FIGURE 28
GENE EDITING MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 29
GENE EDITING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
 
 
 
 
 
 
FIGURE 30
EV/EBITDA OF KEY PLAYERS
 
 
 
 
 
 
FIGURE 31
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY PLAYERS
 
 
 
 
 
 
FIGURE 32
GENE EDITING MARKET: BRAND COMPARATIVE ANALYSIS
 
 
 
 
 
 
FIGURE 33
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 34
AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 35
MERCK KGAA: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 36
REVVITY, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 37
GENSCRIPT: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 38
LONZA: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 39
TECAN TRADING AG: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 40
SANGAMO THERAPEUTICS: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 41
PRECISION BIOSCIENCES: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 42
CELLECTIS S.A.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 43
REGENERON PHARMACEUTICALS, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 44
TAKARA BIO INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 45
CARIBOU BIOSCIENCES, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 46
REPROCELL INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 47
RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 48
GENE EDITING MARKET: BREAKDOWN OF PRIMARIES
 
 
 
 
 
 
FIGURE 49
GENE EDITING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025
 
 
 
 
 
 
FIGURE 50
MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2025
 
 
 
 
 
 
FIGURE 51
REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC. (2025)
 
 
 
 
 
 
FIGURE 52
MARKET SIZE VALIDATION FROM PRIMARY SOURCES
 
 
 
 
 
 
FIGURE 53
MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 54
GENE EDITING MARKET CAGR PROJECTIONS:
 
 
 
 
 
 
FIGURE 55
DATA TRIANGULATION METHODOLOGY
 
 
 
 
 
 

Methodology

This study involved four major activities in estimating the current size of the gene editing market. Exhaustive secondary research was conducted to gather information on the market, its peer markets, and its parent market. These findings, assumptions, and sizing were then validated with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Following this, the data triangulation procedure was used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was used primarily to identify and gather information for this extensive, technical, market-oriented, and commercial study. The secondary sources referred to for this research study include publications from government sources, such as the National Center for Biotechnology Information (NCBI), National Institutes of Health (NIH), World Health Organization (WHO), Food and Drug Administration (FDA), European Medicines Agency (EMA), Pharmaceutical Research and Manufacturers of America (PhRMA), Global Cancer Observatory (GLOBOCAN), Centers for Disease Control and Prevention (CDC), and European Federation of Biotechnology. Secondary sources also included corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. These sources were also used to obtain key information on major players, global product revenues, market classification, and segmentation by industry trends, regional/country-level markets, market developments, and technology perspectives. Secondary data were collected and analyzed to determine the overall size of the global gene editing market, and the findings were validated through primary research.

Primary Research

In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and assess market prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Gene Editing Market 
 Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global gene editing market size was estimated using multiple approaches. A detailed market estimation approach was used to estimate and validate the market value and other dependent submarkets. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:

Gene Editing Market Top Down and Bottom Up Approach

Data Triangulation

After estimating the overall market size from the market size estimation process, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments, the data triangulation procedure was employed; it involved studying various factors and trends from both the demand and supply sides.

Market Definition

Gene editing refers to technologies used to modify, insert, delete, or regulate specific DNA sequences in cells and organisms. These technologies enable targeted genetic modifications through approaches such as CRISPR-Cas, transcription activator-like effector nucleases (TALENs), zinc finger nucleases (ZFNs), base editing, and other genome engineering techniques. The gene editing market includes products such as reagents & consumables and software & systems, as well as specialized services such as cell line development & characterization, gRNA synthesis & vector construction, and library construction & screening. These products and services are widely used in cell line engineering, genome editing, drug discovery and development, and genetic research. They also support applications in biotechnology, biopharmaceutical production, and therapeutic development. Rising investment in genetic research, advances in genome-editing technologies, and the growing adoption of precision medicine are driving demand for gene editing products and services across pharmaceutical, biotechnology, and academic research institutions.

Key Stakeholders

  • Academic Research Institutes
  • Raw Materials Manufacturers & Distributors
  • Contract Research Organizations (CROs)
  • Service Providers
  • Market Research and Consulting Firms
  • Pharmaceutical & Biotechnology Companies
  • Regulatory Agencies
  • Venture Capitalists
  • Government Organizations
  • Private Research Firms
  • Contract Development and Manufacturing Organizations (CDMOs)

Report Objectives

  • To define, describe, and forecast the gene editing market by product & service, technology, application, end user, and region
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall gene editing market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil and the Rest of Latin America), the Middle East (GCC Countries and the Rest of the Middle East), and Africa
  • To profile the key players and analyze their market shares and core competencies
  • To track and analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions
  • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

Available customizations:

Based on the market data, MarketsandMarkets offers customizations to meet the company’s specific needs. The following customization options are available for the report:

Geographical Analysis

  • Further breakdown of the market in the Rest of Europe, by country
  • Further breakdown of the market in the Rest of Asia Pacific, by country

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

Segment Analysis

  • Cross-segment analysis

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Gene Editing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Gene Editing Market

THIS REPORT TELLS YOU

How big the Gene Editing market is, and who leads it.

GROWTHIQ TELLS YOU NEW

Where your company should play next, and who is taking your share.

Get your company's view of this market. Free snapshot.

DMCA.com Protection Status
popup img